Osseon Therapeutics Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2013 | $16 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Osseon Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2013).
SEC Form D · Feb 2013
The industry group it chose in its notices: Other Health Care.
SEC Form D · Feb 2013
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Osseon Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Ronald Clough | Executive officer | Feb 2013 |
| David Pelizzon | Director | Feb 2013 |
| Dennis McGowan | Director | Feb 2013 |
| Don Grant | Director | Feb 2013 |
| Doug Clark | Director | Feb 2013 |
| Doug Pascoe | Director | Feb 2013 |
| John O'Donnell | Director | Feb 2013 |
| John Stalcup | Director | Feb 2013 |